Learn More
Echelon Biosciences Research Labs BrP-LPA 1 mg

Supplier: Echelon Biosciences Research Labs L74161MG
BrP-LPA, aka LPA bromophosphonate, acts as both an Autotaxin inhibitor (94% inhibition at 10 M) and pan LPA receptor antagonist (LPA1: 1.5 M, LPA2: 1.4 M, LPA3: 1.2 M, LPA4: 0.27 M). BrP-LPA inhibits the invasiveness of NIH3T3 ras ATX cells by 40% and decreases chemotaxis by 23%. BrP-LPA reduces the size of breast (MDA-MB-231), colon (HCT-116) and melanoma (B16F10) tumors in mouse models. It also attenuates collagen-induced arthritis PPAR is not activated by BrP-LPA. This item is non returnable
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.